{"anticipatedPostingDate":"2027-03","denomUnitsSelected":"Participants","description":"OS is defined as the time from the date of randomization until death due to any cause. The OS24 is defined as the Kaplan-Meier estimate of OS at 24 months after randomization.","reportingStatus":"NOT_POSTED","timeFrame":"Month 24","title":"Durvalumab Plus Tremelimumab Combination Versus Placebo: Percentage of Participants Alive at 24 Months From Randomization","type":"SECONDARY"}